Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Quarterly results
Appointed director
|
|
PUMA BIOTECHNOLOGY, INC. (PBYI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/05/2021 |
GN
| Polyphor Announces Financial Results for the Full-Year 2020 |
| 09/03/2020 |
GN
| Knight Therapeutics Announces Filling of Supplement to a New Drug Submission for NERLYNX® (neratinib) to Treat HER2-Positive Metastatic Breast Cancer |
| 09/03/2020 |
GN
| Thérapeutique Knight annonce le dépôt d'un supplément à la présentation de drogue nouvelle pour NERLYNX® (nératinib) pour le traitement du cancer du sein HER2-positif métastatique |
| 07/16/2019 |
GN
| Knight Therapeutics Announces Health Canada Has Approved NERLYNX ® for Early-Stage Breast Cancer |
| 07/16/2019 |
GN
| Thérapeutique Knight annonce l'approbation par Santé Canada de NERLYNX® pour le traitement du cancer du sein au stade précoce |
| 02/28/2019 |
GN
| Predictive Technology Group Names Jay M. Moyes to Its Board of Directors |
| 01/11/2019 |
GN
| Knight Therapeutics Runs with Exclusive Canadian License to Puma's NERLYNX® |
| 01/11/2019 |
GN
| Thérapeutique Knight exploite une licence canadienne exclusive pour le produit NERLYNX® de Puma |
| 08/23/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Patterson-UTI Energy, Puma Biotechnology, Echelon, McEwen Mining, New Gold, and Qudian Inc. Sponsored ADR — New Research Emphasizes Economic Growth |
| 06/12/2018 |
GN
| Detailed Research: Economic Perspectives on Amphenol, Hologic, Newell Brands, Ciena, SAExploration, and Puma Biotechnology — What Drives Growth in Today's Competitive Landscape |
| 12/12/2017 |
GN
| Update in Lawsuit for Investors in Puma Biotechnology Inc (NYSE:PBYI) shares announced by Shareholders Foundation |
| 12/04/2017 |
GN
| Analysis: Positioning to Benefit within Emerson Electric, Puma Biotechnology, Amgen, SunCoke Energy Partners, Carrols Restaurant Group, and First Financial — Research Highlights Growth, Revenue, and Consolidated Results |
| 06/01/2017 |
GN
| PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm |
| 05/22/2017 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline – PBYI |
| 05/17/2017 |
GN
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017 |
| 05/15/2017 |
GN
| The Klein Law Firm Announces a Class Action Filed on Behalf of Puma Biotechnology, Inc. Shareholders and a Lead Plaintiff Deadline of July 7, 2017 (PBYI) |
| 05/11/2017 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 – PBYI |
| 05/10/2017 |
GN
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Puma Biotechnology, Inc. (Nasdaq: PBYI) To Contact Brower Piven Before The Lead Plaintiff Deadline |
| 05/08/2017 |
GN
| Pomerantz Law Firm Announces the Filing of a Class Action against Puma Biotechnology, Inc. and Certain Officers – PBYI |
|
|